Performance and prognostic utility of the 92-gene assay in the molecular subclassification of ampullary adenocarcinoma.

For the 92-gene classifier, the difference in OS for the intestine versus pancreaticobiliary main cancer type predictions bordered on significance (median OS 108.1 v 36.4 months; P = 0.05) and RFS ( P = 0.024) (Table 1 and Fig. 2c ).

also in 114 other papers